Latest news with #EMG
Yahoo
3 days ago
- Business
- Yahoo
Wearable Devices Receives U.S. Patent for Innovative Gesture Control, Enabling Precision Interaction with Digital Devices
Yokneam Illit, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the 'Company' or 'Wearable Devices') (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence ('AI")-powered touchless sensing wearables, recently announced that the United States Patent and Trademark Office has granted a continuation of its patent titled 'Gesture and Voice-Controlled Interface Device', strengthening its leadership in revolutionizing intuitive human-device interactions for next-generation digital ecosystems. Traditional gesture sensing systems continuously track hand and finger movements but lack clear "start" and "end" points, making it difficult for devices to understand when a user truly intends to zoom, adjust volume, or manipulate an object. As a result, unintuitive solutions have been used - such as requiring the use of both hands, adding special buttons, or abandoning continuous control altogether. The same goes for voice assistants, which require a 'wake word', prompting them to wait for further instructions. Wearable Devices' newly allowed patent defines a method to extract precise start and end points from continuous gestures. This breakthrough enables devices to support natural and intuitive control gestures like pinch-to-zoom not just for zooming images, but also for adjusting volume, resizing objects, or moving elements - seamlessly and touch-free. The technology is ideally suited for augmented reality ('AR') headsets, gesture-controlled smart devices, and wearable controllers based on cameras, Inertial Measurement Unit (IMU), or electromyography (EMG) sensors - making mid-air fine control finally accessible and natural. About Wearable Devices Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a growth company pioneering human-computer interaction through its AI-powered neural input touchless technology. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company's consumer products - the Mudra Band and Mudra Link - are defining the neural input category both for wrist-worn devices and for brain-computer interfaces. These products enable touch-free, intuitive control of digital devices using gestures across multiple operating systems. Operating through a dual-channel model of direct-to-consumer sales and enterprise licensing and collaborations, Wearable Devices empowers consumers with stylish, functional wearables for enhanced experiences in gaming, productivity, and extended reality ('XR'). In the business sector, the Company provides enterprise partners with advanced input solutions for immersive and interactive environments, from AR/virtual reality ('VR')/XR to smart environments. By setting the standard for neural input in the XR ecosystem, Wearable Devices is shaping the future of seamless, natural user experiences across some of the world's fastest-growing tech markets. Wearable Devices' ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols 'WLDS' and 'WLDSW,' respectively. Forward-Looking Statements Disclaimer This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the 'safe harbor' created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as 'believe,' 'expect,' 'may,' 'should,' 'could,' 'seek,' 'intend,' 'plan,' 'goal,' 'estimate,' 'anticipate' or other comparable terms. For example, we are using forward-looking statements when we discuss the benefits and advantages of our products and technology, our aim to make neural input as intuitive and accessible as possible, and the potential of our touchless control technology in enabling devices to support natural and intuitive control gestures. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the trading of our ordinary shares or warrants and the development of a liquid trading market; our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our annual report on Form 20-F for the year ended December 31, 2024, filed on March 20, 2025 and our other filings with the SEC. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. Investor Relations Contact Michal Efraty IR@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
3 days ago
- Business
- Associated Press
Wearable Devices Receives U.S. Patent for Innovative Gesture Control, Enabling Precision Interaction with Digital Devices
Yokneam Illit, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the 'Company' or 'Wearable Devices') (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence ('AI')-powered touchless sensing wearables, recently announced that the United States Patent and Trademark Office has granted a continuation of its patent titled 'Gesture and Voice-Controlled Interface Device', strengthening its leadership in revolutionizing intuitive human-device interactions for next-generation digital ecosystems. Traditional gesture sensing systems continuously track hand and finger movements but lack clear 'start' and 'end' points, making it difficult for devices to understand when a user truly intends to zoom, adjust volume, or manipulate an object. As a result, unintuitive solutions have been used - such as requiring the use of both hands, adding special buttons, or abandoning continuous control altogether. The same goes for voice assistants, which require a 'wake word', prompting them to wait for further instructions. Wearable Devices' newly allowed patent defines a method to extract precise start and end points from continuous gestures. This breakthrough enables devices to support natural and intuitive control gestures like pinch-to-zoom not just for zooming images, but also for adjusting volume, resizing objects, or moving elements - seamlessly and touch-free. The technology is ideally suited for augmented reality ('AR') headsets, gesture-controlled smart devices, and wearable controllers based on cameras, Inertial Measurement Unit (IMU), or electromyography (EMG) sensors - making mid-air fine control finally accessible and natural. About Wearable Devices Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a growth company pioneering human-computer interaction through its AI-powered neural input touchless technology. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company's consumer products - the Mudra Band and Mudra Link - are defining the neural input category both for wrist-worn devices and for brain-computer interfaces. These products enable touch-free, intuitive control of digital devices using gestures across multiple operating systems. Operating through a dual-channel model of direct-to-consumer sales and enterprise licensing and collaborations, Wearable Devices empowers consumers with stylish, functional wearables for enhanced experiences in gaming, productivity, and extended reality ('XR'). In the business sector, the Company provides enterprise partners with advanced input solutions for immersive and interactive environments, from AR/virtual reality ('VR')/XR to smart environments. By setting the standard for neural input in the XR ecosystem, Wearable Devices is shaping the future of seamless, natural user experiences across some of the world's fastest-growing tech markets. Wearable Devices' ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols 'WLDS' and 'WLDSW,' respectively. Forward-Looking Statements Disclaimer This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the 'safe harbor' created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as 'believe,' 'expect,' 'may,' 'should,' 'could,' 'seek,' 'intend,' 'plan,' 'goal,' 'estimate,' 'anticipate' or other comparable terms. For example, we are using forward-looking statements when we discuss the benefits and advantages of our products and technology, our aim to make neural input as intuitive and accessible as possible, and the potential of our touchless control technology in enabling devices to support natural and intuitive control gestures. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the trading of our ordinary shares or warrants and the development of a liquid trading market; our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our annual report on Form 20-F for the year ended December 31, 2024, filed on March 20, 2025 and our other filings with the SEC. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. Investor Relations Contact Michal Efraty [email protected]
Yahoo
3 days ago
- Business
- Yahoo
Wearable Devices Receives U.S. Patent for Innovative Gesture Control, Enabling Precision Interaction with Digital Devices
Yokneam Illit, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the 'Company' or 'Wearable Devices') (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence ('AI")-powered touchless sensing wearables, recently announced that the United States Patent and Trademark Office has granted a continuation of its patent titled 'Gesture and Voice-Controlled Interface Device', strengthening its leadership in revolutionizing intuitive human-device interactions for next-generation digital ecosystems. Traditional gesture sensing systems continuously track hand and finger movements but lack clear "start" and "end" points, making it difficult for devices to understand when a user truly intends to zoom, adjust volume, or manipulate an object. As a result, unintuitive solutions have been used - such as requiring the use of both hands, adding special buttons, or abandoning continuous control altogether. The same goes for voice assistants, which require a 'wake word', prompting them to wait for further instructions. Wearable Devices' newly allowed patent defines a method to extract precise start and end points from continuous gestures. This breakthrough enables devices to support natural and intuitive control gestures like pinch-to-zoom not just for zooming images, but also for adjusting volume, resizing objects, or moving elements - seamlessly and touch-free. The technology is ideally suited for augmented reality ('AR') headsets, gesture-controlled smart devices, and wearable controllers based on cameras, Inertial Measurement Unit (IMU), or electromyography (EMG) sensors - making mid-air fine control finally accessible and natural. About Wearable Devices Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a growth company pioneering human-computer interaction through its AI-powered neural input touchless technology. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company's consumer products - the Mudra Band and Mudra Link - are defining the neural input category both for wrist-worn devices and for brain-computer interfaces. These products enable touch-free, intuitive control of digital devices using gestures across multiple operating systems. Operating through a dual-channel model of direct-to-consumer sales and enterprise licensing and collaborations, Wearable Devices empowers consumers with stylish, functional wearables for enhanced experiences in gaming, productivity, and extended reality ('XR'). In the business sector, the Company provides enterprise partners with advanced input solutions for immersive and interactive environments, from AR/virtual reality ('VR')/XR to smart environments. By setting the standard for neural input in the XR ecosystem, Wearable Devices is shaping the future of seamless, natural user experiences across some of the world's fastest-growing tech markets. Wearable Devices' ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols 'WLDS' and 'WLDSW,' respectively. Forward-Looking Statements Disclaimer This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the 'safe harbor' created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as 'believe,' 'expect,' 'may,' 'should,' 'could,' 'seek,' 'intend,' 'plan,' 'goal,' 'estimate,' 'anticipate' or other comparable terms. For example, we are using forward-looking statements when we discuss the benefits and advantages of our products and technology, our aim to make neural input as intuitive and accessible as possible, and the potential of our touchless control technology in enabling devices to support natural and intuitive control gestures. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the trading of our ordinary shares or warrants and the development of a liquid trading market; our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our annual report on Form 20-F for the year ended December 31, 2024, filed on March 20, 2025 and our other filings with the SEC. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. Investor Relations Contact Michal Efraty IR@ in to access your portfolio
Yahoo
7 days ago
- Business
- Yahoo
Senzime Applauds Announcement of Upcoming European Pediatric Guidelines of Neuromuscular Monitoring
UPPSALA, SE / / May 26, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Lisbon, Portugal - Senzime AB (publ.) welcomes today's pre-announcement of the first pediatric guidelines of quantitative neuromuscular monitoring during anesthesia. The guideline announcement was done at the Euroanaesthesia 2025 (ESAIC) congress in Lisbon with final publication and announcement expected later in 2025, representing a significant update to pediatric anesthesia practice. "Pediatric patients have long been underserved when it comes to neuromuscular monitoring," commented Philip Siberg, CEO of Senzime. "Today's announcements are based on analysis of over 8,000 studies signaling EMG as a recommended monitoring technology in pediatric anesthesia. This represents a pivotal moment for clinicians who want to ensure safety and recovery in the youngest and most vulnerable patients. The announcement further represents a critical step in improving patient safety and presents a substantial market opportunity for our TetraGraph system, a leading EMG-based quantitative train-of-four (TOF) solution."Each year, approximately 10-12 million pediatric major surgeries are performed worldwide with neuromuscular blocking drugs, with around 3 million in the US alone. Research has shown that without proper monitoring, over 40% of pediatric patients experience residual neuromuscular block (rNMB) postoperatively, leading to respiratory complications, airway obstruction, and delayed the well-documented risks of rNMB, pediatric anesthesia has historically relied on qualitative neuromuscular monitoring or no monitoring at all, due to the lack of specialized pediatric solutions. The pre-announced guidelines call for a recommendation of quantitative neuromuscular monitoring, ensuring that paralytic and reversal drugs are properly dosed, and rNMB is TetraGraph® system is the only neuromuscular monitor on the market with a separate and specific FDA-cleared electromyography (EMG) sensor for use on patients from one month old. Unlike legacy neuromuscular monitors, TetraGraph monitors use EMG to accurately analyze the direct effects of paralytic drugs and does not require free-moving muscles, making it ideal for pediatric and tucked-arm cases such as robotic surgical procedures. For further information, please contact: Philip Siberg, CEO of Senzime ABPhone: +46 (0) 707 90 67 34, e-mail: About Senzime Senzime is a leading medical device company at the forefront of a changing healthcare market, driven by new clinical guidelines and emerging technologies. Established in 1999, Senzime develops and markets precision-based monitoring systems that improve outcomes, reduce costs, and advance perioperative patient safety. The flagship solution is the TetraGraph® system, proven best-in-class for accurate monitoring of neuromuscular transmission during surgery and used in thousands of operating rooms across the globe. The system helps to secure precise dosing of paralytic drugs and provides enhanced insights to safeguard every patient's journey, from anesthesia to in Uppsala, Sweden, Senzime is publicly traded on the Nasdaq Stockholm Main Market (SEZI), with cross-trading on the US OTCQX Market (SNZZF), and backed by long-term investors. More information is available at Attachments Senzime applauds announcement of upcoming European pediatric guidelines of neuromuscular monitoring SOURCE: Senzime View the original press release on ACCESS Newswire
Yahoo
14-05-2025
- Health
- Yahoo
I was living with ALS symptoms for years before I was diagnosed in my 40s. The signs you shouldn't ignore — and the reality of living with a terminal illness
May is ALS Awareness Month — an important cause to Stephanie Thompson. The Ottawa-based mom was in her early 40s when she began noticing the first signs of amyotrophic lateral sclerosis (ALS). The now 44-year-old was experiencing 'weird muscle cramps' that would occur seemingly out of nowhere. "It's normal to get cramps in your feet, and I had those too, so I didn't think much of it," she said in an interview with Yahoo Canada. "But then I'd be brushing my hair and my hand would seize up, clamping around the brush so tightly I had to pry my fingers loose.' The cramping worsened over time to the point that she recalled not being able to lift her head from her pillow. Still, it would be two years before Thompson felt they were serious enough to see a doctor. This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle. 'My three boys — 15, 13, and 6 — took up a lot of time, and there was always something going on,' she explained. 'I kept putting [my health] on the back burner. But then I had this feeling — it can't be normal because it lasted too long.' In September 2023, two years after she first began noticing symptoms, the cramps had progressed to the point where Thompson needed to brace herself to stand up. Her doctor referred her to a specialist for an Electromyography (EMG), a procedure that measures muscle and nerve function. "My first EMG and physical exam showed weakness, but I didn't get the results then,' Thompson said. Thompson was referred to a neurologist in December 2023 for more tests and a second EMG; a month later, she received an MRI. February brought more tests and another EMG. Five months after she visited her doctor for her symptoms she received the devastating diagnosis: she had ALS. 'I went to a very dark place where I couldn't function…,' she said. 'You think about your life, even just the day before the diagnosis, and you start grieving the future you thought you'd have. It's like, that's not going to happen now.' Despite the heartbreak of learning she has ALS, Thompson acknowledged that she received her diagnosis relatively quickly. Dr. Lorne Zinman, head of Sunnybrook Hospital's ALS Clinic in Toronto agreed. Most family doctors will encounter only one or two ALS cases in their entire careerDr. Lorne Zinman 'In Canada, it typically takes patients one and a half to two years from their first symptom to receive a diagnosis,' he explained in a separate interview with Yahoo Canada. One reason for the delayed diagnosis is that ALS has no 'diagnostic biomarkers' and a diagnosis is made 'ruling out every other possibility. Adding to the challenge is the disease's rarity. ALS affects only two to three people per 100,000 annually, and there's a lack of awareness among general practitioners. View this post on Instagram A post shared by Stephanie Thompson (@alsgetsonmynerves) 'Most family doctors will encounter only one or two ALS cases in their entire career,' says Zinman. 'Stroke, by comparison, is far more common." ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder. It destroys the nerve cells that control muscles, severely impairing speech, swallowing, movement, and eventually breathing. Unfortunately, today, there is no cure. Approximately 3,000 people in Canada are diagnosed with ALS each year; one thousand Canadians die annually from the disease. The life expectancy for people with ALS varies, however Health Canada reports that 80 per cent of people die two to five years after their diagnosis. 'For reasons we don't fully understand, yet, the nerves controlling muscles begin to degenerate,' said Zinman. 'In most patients, the disease starts in one region of the body. If it begins with speech or swallowing, it's called bulbar-onset ALS; if it starts in the arms or legs, it's known as spinal-onset ALS.' Living with ALS comes with a huge financial burden, something that Thompson and her fiancé Devin Duquette, have learned first-hand. They purchased a home in July 2023, seven months before Thompson received her diagnosis. 'Unfortunately, we did not get insurance on the mortgage. That was a financial hit for us because we have to maintain that mortgage throughout this process,' explained Thompson. In addition, the new home required upgrades such as the chair lift to help keep her as mobile as possible. Since the pandemic, Thompson had been working remotely for a corporate bank. Although the job wasn't physically demanding, she ultimately had to stop working. 'I came to the point where the physical requirement to even be at a desk for that long was something that I couldn't do," she said. "Because of the continuous typing, I'll cramp up my hands. And then there was the stress of work and [after the diagnosis] the stress of [learning that] I'm dying.' Despite the public health care system and provincial home care programs that offer some support, coverage is inconsistent across Canada. Families must grapple with the expensive treatments and out-of-pocket costs of medicines and specialized equipment that could provide comfort and care. The ALS Society of Canada says the average financial burden a household incurs with a member living with ALS between $150,000 and $250,000 over the course of the disease. It's considered the "bankruptcy disease" because the yearly cost of ALS care is much higher than that for people living with HIV/AIDS, stroke survivors in their first year, or those with Alzheimer's. With a reduced income, keeping up with everything is challengingStephanie Thompson Although Thompson received help from the ALS Society of Canada, she and Duquette turned to GoFundMe to help raise money for bedroom equipment 'With a reduced income, keeping up with everything is challenging. The ALS Society of Canada provides some devices and equipment, but you don't have a say in what you receive. For example, I had to pay out of pocket for specific bathroom equipment,' she said. View this post on Instagram A post shared by Stephanie Thompson (@alsgetsonmynerves) As per the ALS Society of Canada, the direct costs associated with ALS (including medical expenses, mobility aids, home modifications, and specialized services) on average add up to $32,337 per year, with families paying about 61 per cent of that — approximately $19,574 — out of pocket. Indirect costs, which are a result of loss of job or unpaid caregiving responsibility are an approximately an additional $56,821 annually. Private insurance has been crucial in covering ALS-related expenses. 'Critical illness insurance helped with some costs, and the Assistive Devices Program will partially cover a specialized electric chair— which costs as much as a car— but I'll have to cover the rest,' she said. Thompson has also turned to social media for support. In addition to her GoFundMe page, she has an Amazon wish list that includes items like a hydration system for people with limited mobility and a hand splint to help straighten her fingers. 'I'm grateful to social media for connecting me with the community. If someone wants to help but can't donate directly, an Amazon wish list with a $30 item could be a way. I'm happy with whatever works for them,' said Thompson. Social media is not only a way for Thompson to connect with the community but also raise awareness for ALS. She's documenting her ALS journey on Instagram through her handle ALS Gets On My Nerves. The guilt of this is something that I'm still working through. I'm proud how of Devin and my kids have adapted into our new Thompson 'This happened [to me] for a reason and I'm going to make the most of it to spread awareness because there's never enough awareness," she said. Amid the chaos, Thompson and Duquette got engaged on Dec 31, 2021. 'The future we thought we would have isn't there. To pivot and to become one of my caregivers has been inspiring to me. He has to carry the household plus take care of me,' she says. 'His workload has increased substantially and he does it out of love. It's not the future that I thought we would be having. But I can't control it. The guilt of this is something that I'm still working through. I'm proud how of Devin and my kids have adapted into our new normal. 'We had a few detours and side quests along the way but are planning on getting married this year. Creating memories and finding our own joy and happiness throughout this journey is our primary objective.'
